Free Trial

CIBC Private Wealth Group LLC Sells 88,219 Shares of Equifax Inc. (NYSE:EFX)

Equifax logo with Business Services background
Remove Ads

CIBC Private Wealth Group LLC decreased its holdings in shares of Equifax Inc. (NYSE:EFX - Free Report) by 94.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,622 shares of the credit services provider's stock after selling 88,219 shares during the period. CIBC Private Wealth Group LLC's holdings in Equifax were worth $1,395,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in the business. Norges Bank acquired a new stake in shares of Equifax in the 4th quarter worth about $330,400,000. Van ECK Associates Corp lifted its holdings in shares of Equifax by 95.9% in the fourth quarter. Van ECK Associates Corp now owns 1,617,574 shares of the credit services provider's stock valued at $412,239,000 after purchasing an additional 791,730 shares in the last quarter. Raymond James Financial Inc. purchased a new position in shares of Equifax during the fourth quarter valued at approximately $113,896,000. Franklin Resources Inc. boosted its position in shares of Equifax by 34.2% during the third quarter. Franklin Resources Inc. now owns 863,718 shares of the credit services provider's stock valued at $251,480,000 after buying an additional 220,109 shares during the last quarter. Finally, Boston Partners grew its holdings in Equifax by 18.0% during the fourth quarter. Boston Partners now owns 1,228,741 shares of the credit services provider's stock worth $313,213,000 after buying an additional 187,460 shares in the last quarter. 96.20% of the stock is owned by institutional investors.

Equifax Price Performance

Shares of EFX stock traded up $4.59 during trading on Tuesday, hitting $213.28. The company had a trading volume of 219,861 shares, compared to its average volume of 1,090,288. The stock's 50-day moving average is $246.77 and its two-hundred day moving average is $260.42. The stock has a market capitalization of $26.62 billion, a price-to-earnings ratio of 44.16, a price-to-earnings-growth ratio of 2.79 and a beta of 1.65. The company has a quick ratio of 0.88, a current ratio of 0.75 and a debt-to-equity ratio of 0.90. Equifax Inc. has a 52 week low of $202.23 and a 52 week high of $309.63.

Remove Ads

Equifax (NYSE:EFX - Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The credit services provider reported $2.12 EPS for the quarter, hitting analysts' consensus estimates of $2.12. Equifax had a net margin of 10.63% and a return on equity of 19.13%. As a group, analysts predict that Equifax Inc. will post 7.58 EPS for the current fiscal year.

Equifax Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Friday, February 21st were given a $0.39 dividend. The ex-dividend date was Friday, February 21st. This represents a $1.56 dividend on an annualized basis and a yield of 0.73%. Equifax's payout ratio is 32.30%.

Wall Street Analyst Weigh In

A number of research firms have issued reports on EFX. Gordon Haskett raised shares of Equifax to a "strong-buy" rating in a report on Tuesday, February 18th. Jefferies Financial Group cut their target price on Equifax from $340.00 to $300.00 and set a "buy" rating on the stock in a research note on Wednesday, January 15th. Needham & Company LLC decreased their price target on Equifax from $325.00 to $300.00 and set a "buy" rating for the company in a research report on Friday, February 7th. Barclays reissued an "equal weight" rating and issued a $260.00 price objective (down previously from $325.00) on shares of Equifax in a research report on Friday. Finally, Wells Fargo & Company decreased their target price on Equifax from $321.00 to $313.00 and set an "overweight" rating for the company in a research report on Monday, February 3rd. Five research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Equifax presently has a consensus rating of "Moderate Buy" and a consensus target price of $294.50.

Get Our Latest Research Report on EFX

About Equifax

(Free Report)

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.

Read More

Institutional Ownership by Quarter for Equifax (NYSE:EFX)

Should You Invest $1,000 in Equifax Right Now?

Before you consider Equifax, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Equifax wasn't on the list.

While Equifax currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

5 Stocks to BUY Now as Tariff Uncertainty Fades
WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads